rs121908254
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_133459.4(CCBE1):c.520T>C(p.Cys174Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_133459.4 missense
Scores
Clinical Significance
Conservation
Publications
- Hennekam lymphangiectasia-lymphedema syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Hennekam syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_133459.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCBE1 | NM_133459.4 | MANE Select | c.520T>C | p.Cys174Arg | missense | Exon 5 of 11 | NP_597716.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCBE1 | ENST00000439986.9 | TSL:1 MANE Select | c.520T>C | p.Cys174Arg | missense | Exon 5 of 11 | ENSP00000404464.2 | ||
| CCBE1 | ENST00000695904.1 | c.520T>C | p.Cys174Arg | missense | Exon 5 of 11 | ENSP00000512259.1 | |||
| CCBE1 | ENST00000649564.1 | c.520T>C | p.Cys174Arg | missense | Exon 6 of 12 | ENSP00000497183.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152114Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251246 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461382Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726988 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74440 show subpopulations
ClinVar
Submissions by phenotype
Hennekam lymphangiectasia-lymphedema syndrome 1 Pathogenic:1Other:1
not provided Pathogenic:1
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 174 of the CCBE1 protein (p.Cys174Arg). This variant is present in population databases (rs121908254, gnomAD 0.004%). This missense change has been observed in individuals with Hennekam lymphangiectasia-lymphedema syndrome (PMID: 19935664, 23653581). ClinVar contains an entry for this variant (Variation ID: 450). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CCBE1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CCBE1 function (PMID: 19935664). This variant disrupts the p.Cys174 amino acid residue in CCBE1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23653581, 26686525, 32472549). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at